Discontinuation report KEVZARA

Last updated on 2022-08-02 History
Report ID 164491
Drug Identification Number 02460521
Brand name KEVZARA
Common or Proper name Kevzara
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) SARILUMAB
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2
ATC code L04AC
ATC description IMMUNOSUPPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-07-29
Actual discontinuation date 2022-07-29
Remaining supply date 2023-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-08-02 French Compare
v4 2022-08-02 English Compare
v3 2022-07-12 French Compare
v2 2022-07-12 French Compare
v1 2022-07-12 English Compare

Showing 1 to 5 of 5